The lecture will review the conceptualization of Mild Cognitive Impairment (MCI) as a clinical entity. Strategies for identifying MCI using both objective and subjective sources of information will be discussed. An Emphasis will be placed on the development of a deeper understanding of the components of commonly used cognitive screening tools (e.g. Montreal Cognitive Assessment).
(Please Note: Session only open to Stony Brook Medicine Physicians, Nurses, Medical Students and Stony Brook Medicine Affiliates)
Dates and Times
Start: 12/19/2018 10:15 AM
End: 12/19/2018 11:15 AM
Have a greater understanding of the relationship between subjective complaints of cognitive difficulty and neurologically based cognitive dysfunction.
Recognize the limitations of commonly used dementia screening tools in the identification of mild cognitive difficulties
Stony Brook Medicine
Health Science Center
Prev Med Seminar Room HSC L3-066
Stony Brook, NY 11784
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.